Merck Return on Tangible Equity 2010-2024 | MKKGY
Current and historical return on tangible equity values for Merck (MKKGY) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Merck Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2024-06-30 |
$2.84B |
$4.40B |
80.92% |
| 2024-03-31 |
$2.96B |
$3.70B |
100.85% |
| 2023-12-31 |
$3.06B |
$2.55B |
131.40% |
| 2023-09-30 |
$3.09B |
$3.39B |
175.22% |
| 2023-06-30 |
$3.22B |
$2.08B |
292.70% |
| 2023-03-31 |
$3.37B |
$1.29B |
715.33% |
| 2022-12-31 |
$3.51B |
$0.30B |
-698.90% |
| 2022-09-30 |
$3.76B |
$0.73B |
-246.72% |
| 2022-06-30 |
$3.73B |
$-0.43B |
-134.40% |
| 2022-03-31 |
$3.70B |
$-2.60B |
-91.41% |
| 2021-12-31 |
$3.62B |
$-3.79B |
-72.25% |
| 2021-09-30 |
$3.20B |
$-4.27B |
-53.91% |
| 2021-06-30 |
$3.25B |
$-5.54B |
-47.54% |
| 2021-03-31 |
$2.67B |
$-6.42B |
-35.20% |
| 2020-12-31 |
$2.27B |
$-7.53B |
-27.87% |
| 2020-09-30 |
$2.12B |
$-7.82B |
-24.57% |
| 2020-06-30 |
$1.56B |
$-8.54B |
-20.88% |
| 2020-03-31 |
$1.77B |
$-8.68B |
-28.62% |
| 2019-12-31 |
$1.48B |
$-9.41B |
-29.86% |
| 2019-09-30 |
$4.00B |
$-3.18B |
-107.87% |
| 2019-06-30 |
$4.02B |
$-3.41B |
-87.07% |
| 2019-03-31 |
$3.78B |
$-3.80B |
-66.02% |
| 2018-12-31 |
$3.99B |
$-4.45B |
-57.36% |
| 2018-09-30 |
$2.27B |
$-6.79B |
-28.22% |
| 2018-06-30 |
$2.63B |
$-7.88B |
-29.68% |
| 2018-03-31 |
$2.80B |
$-8.68B |
-29.54% |
| 2017-12-31 |
$2.94B |
$-8.85B |
-29.30% |
| 2017-09-30 |
$2.06B |
$-10.10B |
-19.04% |
| 2017-06-30 |
$1.82B |
$-10.31B |
-15.95% |
| 2017-03-31 |
$1.71B |
$-10.85B |
-14.13% |
| 2016-12-31 |
$1.80B |
$-12.11B |
-14.27% |
| 2016-09-30 |
$1.65B |
$-12.26B |
-12.64% |
| 2016-06-30 |
$1.55B |
$-13.06B |
-16.71% |
| 2016-03-31 |
$1.58B |
$-13.09B |
-29.15% |
| 2015-12-31 |
$1.25B |
$-13.85B |
-80.53% |
| 2015-09-30 |
$1.42B |
$2.91B |
69.29% |
| 2015-06-30 |
$1.35B |
$2.39B |
95.59% |
| 2015-03-31 |
$1.37B |
$2.36B |
185.89% |
| 2014-12-31 |
$1.50B |
$0.54B |
219.93% |
| 2014-09-30 |
$1.56B |
$0.34B |
165.63% |
| 2014-06-30 |
$1.68B |
$-0.29B |
164.12% |
| 2014-03-31 |
$1.70B |
$2.13B |
156.26% |
| 2013-12-31 |
$1.60B |
$1.60B |
354.27% |
| 2013-09-30 |
$1.56B |
$0.66B |
-1314.29% |
| 2013-06-30 |
$1.35B |
$-0.05B |
-282.77% |
| 2013-03-31 |
$0.85B |
$-0.41B |
-112.82% |
| 2012-12-31 |
$0.73B |
$-0.68B |
-111.74% |
| 2012-09-30 |
$0.55B |
$-0.77B |
-60.09% |
| 2012-06-30 |
$0.64B |
$-1.15B |
-88.02% |
| 2012-03-31 |
$0.60B |
|
-64.31% |
| 2011-12-31 |
$0.84B |
$-1.77B |
-90.60% |
| 2011-09-30 |
$0.75B |
|
-154.81% |
| 2011-06-30 |
$0.70B |
$-1.94B |
-56.92% |
| 2011-03-31 |
$1.05B |
|
-140.27% |
| 2010-12-31 |
$0.84B |
|
-112.11% |
| 2010-09-30 |
$0.83B |
$-3.00B |
-111.18% |
| 2010-06-30 |
$0.77B |
|
inf% |
| 2010-03-31 |
$0.69B |
|
inf% |
| 2009-12-31 |
$0.51B |
|
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
